Role of the clinical pharmacist in outpatient treatment of HCV (hepatitis C virus)

• In: 8F4 - Clinical pearls: Inspiration to improve your future hospital practice on Monday, 8 October 2012, 12:15-13:45
• At: Amsterdam (the Netherlands) (2012)
• Type: Presentations + Posters
• By: BIZJAK, Vesna (Clinical Pharmacy Specialist, Ljubljana, Slovenia)
• Abstract:

  In October 2011 University Medical Centre started a named patient program (NPP; early access; compassionate use) for patients with chronic hepatitis C virus (HCV). Two drugs from the program, telaprevir and boceprevir, are strong inhibitors of cytochrome P450 3A4 and are used in combination with peginterferon alfa and ribavirin. Patients taking

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login